| Financial Year |
September 30 2022 |
| Monetary Funds |
1,035,300,645.06 |
| Held-for-trading Financial Assets |
319,196,801.12 |
| Notes Receivable |
90,969,084.98 |
| Accounts Receivable |
474,788,382.34 |
| Advances to Suppliers |
29,964,710.38 |
| Other Receivables |
9,455,390.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
240,059,676.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
551,058,291.90 |
| Total Current Assets |
2,782,576,858.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,486,589,291.13 |
| Under-construction Projects |
14,618,495.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
107,324,977.11 |
| R&D expenses |
-- |
| Goodwill |
73,127,091.94 |
| Long-Term Deferred and Prepaid Expenses |
59,442,048.69 |
| Deferred Income Tax Assets |
84,520,929.49 |
| Other Non-Current Assets |
241,920,588.09 |
| Sub-Total of Non-Current Assets |
2,156,151,606.45 |
| Total Assets |
4,938,728,465.34 |
| Short-Term Loans |
320,994,039.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
953,571,380.59 |
| Accounts Payable |
192,025,835.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,039,828.93 |
| Taxes Payable |
14,672,482.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
60,183,608.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
89,151,907.31 |
| Other Current Liabilities |
65,019,383.99 |
| Sub-Total of Current Liabilities |
1,749,807,119.32 |
| Long-term Loans |
171,875,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
73,127,091.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
328,931,294.77 |
| Total Liabilities |
2,078,738,414.09 |
| Paid-In Capital(Or Share Stock) |
80,000,000.00 |
| Capital Surplus |
1,945,245,141.63 |
| Surplus Reserve |
60,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
550,610,638.74 |
| Minority Stockholder's Interest |
230,046,303.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,629,943,747.88 |
| Owner's Equity（Stockholder's Equity） |
2,859,990,051.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,938,728,465.34 |
